chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: U
Vaccine: RV5
Symptoms: Gastrointestinal tube insertion, Haematochezia
Clinical narrative: Information has been received from a health professional concerning a patient under 1 year old who was vaccinated with an oral dose of Rotateq. Subsequently the patient experienced a bloody stool. It was reported that the patient had "a G tube" for an unspecified reason. Unspecified medical attention was sought. No product quality complaint was involved. Upon internal review, the patients bloody stool was considered to be an other important medical event. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Grand mal convulsion
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 16 year old female patient who in January 2007 ("last month"), was vaccinated with the first dose, 0.5ml, of Gardasil. The physician reported that in January 2007 ("last month"), the patient experienced a grand mal seizure after receiving her first dose. In addition, the physician reported that the "patient has no history of seizures and was taken to the ER. The physician did not know if the patient was admitted. It was unknown if the patient recovered. Upon internal review, grand mal seizure was determined to be an other medical event. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Anaphylactic reaction, Angioneurotic oedema, Oedema, Pruritus
Clinical narrative: Information has been received from a physician concerning a 6 year old male, who was vaccinated with his second dose of varicella virus vaccine, live. Subsequently the patient experienced anaphylaxis, edema, itching, and mild angioedema. The physician administered BENADRYL, Epi and DECADRON. The physician monitor the patient for about one half hour. The patient was prescribed PERAZONE and released to home. At the time of this report the patient was considered to be recovering. There was no product quality complaint. Unspecified medical attention was sought. The events were considered to be life threatening and other important medical event. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site mass, Injection site pain, Myalgia, Neuralgia
Clinical narrative: pain of muscle/nerve, neck, arm, and upper back. Very tender arm at injection site and knot at injection site. Put on Prednisone and Mobic by doctor after exam of site and pain. 7/19/07-records received-notes from 3/4/07-C/O pain in neck and difficulty moving her head. Received injection in right arm. Symptoms were worse next day, thought it might be neuritis and was started on Medrol dose pack. Pain also in  left shoulder and her entire body hurts. Instructed if symptoms increased to go to ED.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Neck pain, Neuritis, Pain in extremity
Clinical narrative: pain of muscle/nerve, neck, arm, and upper back. Very tender arm at injection site and knot at injection site. Put on Prednisone and Mobic by doctor after exam of site and pain. 7/19/07-records received-notes from 3/4/07-C/O pain in neck and difficulty moving her head. Received injection in right arm. Symptoms were worse next day, thought it might be neuritis and was started on Medrol dose pack. Pain also in  left shoulder and her entire body hurts. Instructed if symptoms increased to go to ED.
Age: 1.25
Sex: F
Vaccine: IPV, MMRV
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure
Age: 85.0
Sex: F
Vaccine: TTOX
Symptoms: Asthenia, Dyskinesia, Headache, Nausea, Pain in extremity
Clinical narrative: I woke up the next morning with a headache, nausea and very sore arm, jaws painful when chewing breakfast.  Not feeling well and very tired (napped a bit during day) for the next two days.  The next day (Sat) woke up feeling a little better but by 9AM after a light breakfast (still a bit nauseous) while still sitting at table. The room started to shift about me.  I felt very weak and nauseous and needed to lye down but couldn't stand called 911 and by 2-3 min my neck started jerking and by 3-4 more min. I was jerking uncontrollable over my whole body. I went to hosp. by ambulance to emergency.  By noon most of the jerking was gone.  I never lost consciousness.  Still tire easily some nausea but headache gone.
Age: 85.0
Sex: F
Vaccine: TTOX
Symptoms: Pain in jaw
Clinical narrative: I woke up the next morning with a headache, nausea and very sore arm, jaws painful when chewing breakfast.  Not feeling well and very tired (napped a bit during day) for the next two days.  The next day (Sat) woke up feeling a little better but by 9AM after a light breakfast (still a bit nauseous) while still sitting at table. The room started to shift about me.  I felt very weak and nauseous and needed to lye down but couldn't stand called 911 and by 2-3 min my neck started jerking and by 3-4 more min. I was jerking uncontrollable over my whole body. I went to hosp. by ambulance to emergency.  By noon most of the jerking was gone.  I never lost consciousness.  Still tire easily some nausea but headache gone.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Amenorrhoea
Clinical narrative: Patient states she missed her menses the month after administration of her first Gardasil injection. Another nurse says she heard another patient say the same thing happened to her, but she couldn't remember the second patient's name in order to fill another report.
Age: 0.16
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Infrequent bowel movements, Irritability
Clinical narrative: Very irritable - atypical for Brady. No BM - 2 days.
Sex: F
Vaccine: TDAP
Symptoms: Influenza
Clinical narrative: I felt it was coincidental flu syndrome but filing report to be cautious
Age: 52.0
Sex: F
Vaccine: HEPAB, TYP, YF
Symptoms: Abdominal pain, Asthenia, Dizziness, Headache, Nausea
Clinical narrative: Client began oral typhoid 3/4/07.  At 9pm began feeling nauseated with abdominal pain, headache, denies fever.  Also dizzy and feeling weak.  Unable to go to work next day.  Called PMD who recommended increased fluids, rest, Benadryl prn and notication of Health Dept
Age: 69.0
Sex: F
Vaccine: RUB
Symptoms: Arthralgia, Conjunctivitis, Lymphadenectomy, Rash macular, Vaccination complication
Clinical narrative: Adverse reaction to Rubella vaccine.  Conjunctivitis, lymphadenopathy, macular rash, arthralgia.  Symptoms started 10 days after vaccine was given.
Age: 56.0
Sex: F
Vaccine: HEP
Symptoms: Lip swelling
Clinical narrative: Pt received third Hepatuitis B vaccine and reported swelling of lips.  No other symptoms reported - pt took antihistamine with reduction of symptoms.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Agitation, Crying
Clinical narrative: The patient has been described as normally fussy after shots.  After vaccination she took a 2 hour nap and upon awakening cried for a total of 3 hours straight. She was better for about 4 hours and then had another 4 hour time period the next morning of prolonged crying.
Age: 45.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Rash maculo-papular
Clinical narrative: generalized maculopapular(>50) located over the neck/waist/B UE/B LE that developed 2 days after receiving the anthrax(#5) and smallpox vaccines, prescribed benadryl 50mg IM today, atarax 25mg q6h or hs prn, zantac 150mg bid, loratadine 10mg qam, and prednisone 60mg taper over 9 days.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Headache, Lymphadenopathy, Pain, Skin warm
Clinical narrative: Patient came into clinic. Lt. arm had whelps from injection site to elbow, swollen, red, and warm to touch.  c/o being achy and headache. States glands in neck are swollen.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Swelling, Urticaria
Clinical narrative: Patient came into clinic. Lt. arm had whelps from injection site to elbow, swollen, red, and warm to touch.  c/o being achy and headache. States glands in neck are swollen.
Age: 0.3
Sex: M
Vaccine: HIBV
Symptoms: Blood test normal, Breath sounds abnormal, Lacrimation increased, Livedo reticularis, Ocular hyperaemia
Clinical narrative: Approximately 10 minutes after receiving Hib vaccine, his skin looked mottled and blotchy and he spit up formula 3 times (he never spits up normally).  Approximately 1 1/2 hours later, his breathing sounded like "snorting", he spit up most of a 4 oz. bottle, and his eyes were watery and red, with redness on the skin around the eyes.  He was seen in the Emergency Room approximately 2 hours after vaccination.  he was thoroughly examined and bloodwork was done - all testing was negative.
Age: 0.3
Sex: M
Vaccine: HIBV
Symptoms: Rash macular
Clinical narrative: Approximately 10 minutes after receiving Hib vaccine, his skin looked mottled and blotchy and he spit up formula 3 times (he never spits up normally).  Approximately 1 1/2 hours later, his breathing sounded like "snorting", he spit up most of a 4 oz. bottle, and his eyes were watery and red, with redness on the skin around the eyes.  He was seen in the Emergency Room approximately 2 hours after vaccination.  he was thoroughly examined and bloodwork was done - all testing was negative.
Age: 0.33
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5, RV5
Symptoms: Intussusception
Clinical narrative: Intussusception 03/08/07-records received from facility for DOS 03/03-03/05/07 DC DX: Intussusception Increased fussiness times one day, the day prior to admission became more fussy, noticed currant jelly stools times three. Presented to PCP palpated sausage like mass in right upper quadrant as well as currant jelly stools. PE: Abdomen positive tenderness to palpation, no masses at that time. Positive for currant jelly stool in diaper. Air contrast enema showed intussusception all way down the descending colon. Reduced by enema. However, no air could be pushed the the ileocecal valve, surgery laparoscopic converted to open reduction of intussusception. Small bowel intussusception into the colon, the appendix was sucked into the intussusception, the intussusceiption went to the beginning of the transverse colon.
Age: 0.33
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5, RV5
Symptoms: Intussusception, Surgery
Clinical narrative: Intussusception 03/08/07-records received from facility for DOS 03/03-03/05/07 DC DX: Intussusception Increased fussiness times one day, the day prior to admission became more fussy, noticed currant jelly stools times three. Presented to PCP palpated sausage like mass in right upper quadrant as well as currant jelly stools. PE: Abdomen positive tenderness to palpation, no masses at that time. Positive for currant jelly stool in diaper. Air contrast enema showed intussusception all way down the descending colon. Reduced by enema. However, no air could be pushed the the ileocecal valve, surgery laparoscopic converted to open reduction of intussusception. Small bowel intussusception into the colon, the appendix was sucked into the intussusception, the intussusceiption went to the beginning of the transverse colon.
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Headache, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: STILL HAVE SWELLING AND TERRIBLE PAIN AT INJECTION SITE (PAIN DIFFERENT THAN  PREVIOUS SHOT)....FEVERED FOR 2 DAYS, AND A TERRIBLE HEADACHE
Age: 35.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Musculoskeletal pain, Pyrexia, Tachycardia
Clinical narrative: Pain at injection site, shoulder pain, lasting 4 days. Fever w/transient tachycardia to 108 bpm (self-report), for one-two days. Alternated application of ice and warm pack, ibuprofen and tylenol. Employee had reported having sore throat day of injection and prior to injection, and that daughter had been ill with flu sxs during week prior.
Age: 1.47
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC, VARCEL
Symptoms: Urticaria, Wheezing
Clinical narrative: About 1715,after vaccine administered (total of six), patient noted with diffuse urticaria.No respiratory but noted mild wheezing. No stridor, RR 20's, unlabored, Pulse ox 98-99%.Rx benadryl 10 mg.po and epinephrine(1:1000)0.1ml IM administered as per Dr. After total observation time of 45 min.Patient ishappy,engaging,with resolving urticaria.D/C with mom with instructions starting 2000. If urticaria resolves and not further problems, RTC 5 days as planned. If urticaria recurs in spite of plan or if he develops respiratory distress of any degree, RTC(ED) promptly.
Age: 0.5
Sex: M
Vaccine: PNC, RV5
Symptoms: Culture stool negative, Haematochezia, Irritability, Pyrexia
Clinical narrative: Mother noted fresh blood in three different stools 2 days (1/31/07)after administration of vaccine.  Pt. had low grade fever, was irritable, but eating well and slept well. Spontaneously resolved with no treatment. No anal fissures noted on evaluation.
Age: 70.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Angiogram, Anxiety, Asthenia, Asthma, Chest X-ray
Clinical narrative: Shortness of breath and weakness, leading to ER visit and hospitalization x 3 days- dx was pulmonary embolism, asthma, anxiety, hypokalemia, hypomagnesemia.   Unknown if related to vaccine. 03/19/07-records received from facility for DOS 2/16-2/19/07-DC DX:Pulmonary embolism, subsegmental nonocculding. Asthma. Anxiety. Hypokalemia. Hypomagnesemia. C/O shortness of breath times 1 week. Productive green cough and post nasal drip. Dyspnea on exertion but no PND or orthopnea. No chest pain but C/O palpatations.  PE:WNL. SOB likely due to underlying asthma exacerbated by viral upper respiratory infection and anxiety. Patients symptoms relieved with lorazepam.
Age: 70.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Computerised tomogram, Condition aggravated, Dyspnoea, Electrocardiogram, Hypokalaemia
Clinical narrative: Shortness of breath and weakness, leading to ER visit and hospitalization x 3 days- dx was pulmonary embolism, asthma, anxiety, hypokalemia, hypomagnesemia.   Unknown if related to vaccine. 03/19/07-records received from facility for DOS 2/16-2/19/07-DC DX:Pulmonary embolism, subsegmental nonocculding. Asthma. Anxiety. Hypokalemia. Hypomagnesemia. C/O shortness of breath times 1 week. Productive green cough and post nasal drip. Dyspnea on exertion but no PND or orthopnea. No chest pain but C/O palpatations.  PE:WNL. SOB likely due to underlying asthma exacerbated by viral upper respiratory infection and anxiety. Patients symptoms relieved with lorazepam.
Age: 70.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Hypomagnesaemia, Pulmonary embolism, Troponin, Ultrasound Doppler
Clinical narrative: Shortness of breath and weakness, leading to ER visit and hospitalization x 3 days- dx was pulmonary embolism, asthma, anxiety, hypokalemia, hypomagnesemia.   Unknown if related to vaccine. 03/19/07-records received from facility for DOS 2/16-2/19/07-DC DX:Pulmonary embolism, subsegmental nonocculding. Asthma. Anxiety. Hypokalemia. Hypomagnesemia. C/O shortness of breath times 1 week. Productive green cough and post nasal drip. Dyspnea on exertion but no PND or orthopnea. No chest pain but C/O palpatations.  PE:WNL. SOB likely due to underlying asthma exacerbated by viral upper respiratory infection and anxiety. Patients symptoms relieved with lorazepam.
Age: 70.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Dyspnoea, Pulmonary embolism
Clinical narrative: Shortness of breath and weakness, leading to ER visit and hospitalization x 3 days- dx was pulmonary embolism, asthma, anxiety, hypokalemia, hypomagnesemia.   Unknown if related to vaccine. 03/19/07-records received from facility for DOS 2/16-2/19/07-DC DX:Pulmonary embolism, subsegmental nonocculding. Asthma. Anxiety. Hypokalemia. Hypomagnesemia. C/O shortness of breath times 1 week. Productive green cough and post nasal drip. Dyspnea on exertion but no PND or orthopnea. No chest pain but C/O palpatations.  PE:WNL. SOB likely due to underlying asthma exacerbated by viral upper respiratory infection and anxiety. Patients symptoms relieved with lorazepam.
Age: 24.0
Sex: M
Vaccine: TTOX
Symptoms: Mobility decreased, Musculoskeletal pain, Reaction to preservatives
Clinical narrative: the morning following the shot, i woke up at 6am from severe pain in my left shoulder where the shot was given. i lost total use of my left arm because of the pain it was causing. the night before i also got a splint on my left ankle from soccer and i was using crutches. i couldnt use cruthches any more because of the pain in my shoulder, therfore i couldnt walk. i missed a lot of time from school and work due top that. i was told when i returned the next day that i had a reaction to the shot although iam not allergic to any medication, i was also told the pain will go away in the next 2 to 3 days. it has been two weeks now and the opain is still there. iam taking medication all day for the pain.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: REDNESS, SWELLING, INTENSE ITCH, 3x3 cm ROUND LOCAL RXN AROUND CHICKEN POX VACCINATION SITE (LEFT ARM)
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, HPV4
Symptoms: Dyspnoea, Throat tightness
Clinical narrative: Ct c/o feeling of throat tightening up and difficulty breathing approx 3 1/2-4 hrs of receiving vaccinations.  Went to bed and next am awake with throat tightness and breathing trouble, but left eye was swollen shut, right eye puffy, hands and arms swollen bilat., temp 100.9, earlobes also swollen, rash with red blotchness right hand. No local reaction, no arthralgia, ct saw pcp on 2/27/07.  Treated with Benadryl 50mg a 6 hour x 2-3 days. Improved substantially by 3/27
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Dyspnoea, Pallor, Pharyngolaryngeal pain, Wheezing
Clinical narrative: Approx. 5-10 minutes after receiving Boostrix and Menactra shots child c/o sore throat and trouble breathing.  Pt pale and mild wheezing.  Xopenex treatment started 2:40pm. Pulse Ox at 2:43pm 89-91% RR20 BP 70/32. Pulse ox at end of treatment 99%. Patient felt he was breathing easier.  BP #2 after 1st treatment was 88154.  Color returned, some wheezing still noted.  Xopenex treatment #2 started at 3:05pm per MD orders.  Pulse ox at that time was 95% doctor reassessed pt after that treatment and released patient with mom.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Blood pressure decreased, Dyspnoea, Oxygen saturation, Oxygen saturation decreased, Oxygen saturation normal
Clinical narrative: Approx. 5-10 minutes after receiving Boostrix and Menactra shots child c/o sore throat and trouble breathing.  Pt pale and mild wheezing.  Xopenex treatment started 2:40pm. Pulse Ox at 2:43pm 89-91% RR20 BP 70/32. Pulse ox at end of treatment 99%. Patient felt he was breathing easier.  BP #2 after 1st treatment was 88154.  Color returned, some wheezing still noted.  Xopenex treatment #2 started at 3:05pm per MD orders.  Pulse ox at that time was 95% doctor reassessed pt after that treatment and released patient with mom.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Pallor, Pharyngolaryngeal pain, Wheezing
Clinical narrative: Approx. 5-10 minutes after receiving Boostrix and Menactra shots child c/o sore throat and trouble breathing.  Pt pale and mild wheezing.  Xopenex treatment started 2:40pm. Pulse Ox at 2:43pm 89-91% RR20 BP 70/32. Pulse ox at end of treatment 99%. Patient felt he was breathing easier.  BP #2 after 1st treatment was 88154.  Color returned, some wheezing still noted.  Xopenex treatment #2 started at 3:05pm per MD orders.  Pulse ox at that time was 95% doctor reassessed pt after that treatment and released patient with mom.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Pain
Clinical narrative: Aftershot, patient developed pain on the side of the body (left) that shot was administered, over left arm, left trunk, and left leg. There was no local redness, swelling, or pain at site of vaccine itself.  The patient was treated with Motrin and ice and resolved after 24 hours.
Age: 11.0
Sex: M
Vaccine: HIBV, IPV, MMR
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: gave child HIB shot at age 11 year old
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: 2nd varicella vaccine given at 3 yrs (not recommended 4 yrs)
Age: 32.0
Sex: F
Vaccine: HEP
Symptoms: Body temperature decreased, Dizziness
Clinical narrative: Immunization (3rd in series) 11:15 am at 1240 approximately 1 1/2 hr later reports dizziness 120/60 78 20 Sat 98 temp 77.9. Approx 1250 ml water po 100/60 80 20, 100/60 71 20 Sat 98%, dizziness resolved.  100/60 86 20 97% 100/70 76 20 Sat 90%
Age: 22.0
Sex: F
Vaccine: ANTH
Symptoms: Abdominal pain upper, Arthralgia, Biopsy liver abnormal, Biopsy skin abnormal, Dermatitis
Clinical narrative: 1. Large local reaction within 2-3 days. Then whole arm and contiguous joint soreness, then other joints sore. 2. July 2000: RUQ pain started: constant, sharp, intermittently elevated LFTs with AST>700, ALT>600, alk phos 200 on at least 2 occasions (now normal lfts, but continuous pain controlled by chronic methadone). 3. Aug 2000: Chronic diarrhea started. 4. November 2000: skin lesions started. AF bx neutrophilic infiltrate. 5. Dec 2000 Lap choly. Now has chronic joint pain, RUQ pain, diarrhea, skin lesions.  03/13/2007 Lengthy MR received.  Initial visit with Infectious Disease MD 8/20/2002 with a 2 year hx of the following c/o:  Chronic RUQ pain, generalized arthralgias, fatigue, insomnia, chronic diarrhea, and skin lesions.  HPI:  Following Anthrax vax in 5/2000, pt initially noticed red bumps around the vaccination site which ultimately ulcerated.  These later progressed to diffuse involvement.  2-3 weeks following vax pt developed muscle soreness and difficulty moving her arm.  Joint pain in the elbow and shoulder followed which ultimately spread to all muscles and joints.  2 months following vax pt developed RUQ pain which was constant and sharp, LFTs elevated. Lap chole in 12/2000 did not improve pain.  Pt. became depressed in 7/2000.  Diarrhea began 8/2000.  Acid reflux/gastritis dx in 8/2000.  Chostochondritis of the right anterior rib cage dx 11/2000.  Skin lesions returned 11/2000 dx as folliculitis with impetigo.  Medical discharge from the service in 12/2001. Pt. still c/o daily RUQ pain, fatigue, intermittent fevers, diffuse symmetrical joint pain with minimal swelling, and skin lesions. DX: Autoimmune hepatitis, Prurigo Nodularis, Transaminitis,  Neutrophilic Infiltrative Disease of unclear etiology, FUO.   05/04/2007 Clinical summary received beginning 1998 through 2004 with the following assessments:  Chronic right upper quadrant pain.  Chronic dermatitis.  Arthralgias.  Myalgias.  Fatigue.  Migraine H/As.  Insomnia.  GERD.  Memory loss.  Tachycardia resolved.  Hypertension.  FUO.  Liver disease-autoimmune.  Depression.
Age: 22.0
Sex: F
Vaccine: ANTH
Symptoms: Diarrhoea, Hepatic fibrosis, Hepatitis, Inflammation, Injection site reaction
Clinical narrative: 1. Large local reaction within 2-3 days. Then whole arm and contiguous joint soreness, then other joints sore. 2. July 2000: RUQ pain started: constant, sharp, intermittently elevated LFTs with AST>700, ALT>600, alk phos 200 on at least 2 occasions (now normal lfts, but continuous pain controlled by chronic methadone). 3. Aug 2000: Chronic diarrhea started. 4. November 2000: skin lesions started. AF bx neutrophilic infiltrate. 5. Dec 2000 Lap choly. Now has chronic joint pain, RUQ pain, diarrhea, skin lesions.  03/13/2007 Lengthy MR received.  Initial visit with Infectious Disease MD 8/20/2002 with a 2 year hx of the following c/o:  Chronic RUQ pain, generalized arthralgias, fatigue, insomnia, chronic diarrhea, and skin lesions.  HPI:  Following Anthrax vax in 5/2000, pt initially noticed red bumps around the vaccination site which ultimately ulcerated.  These later progressed to diffuse involvement.  2-3 weeks following vax pt developed muscle soreness and difficulty moving her arm.  Joint pain in the elbow and shoulder followed which ultimately spread to all muscles and joints.  2 months following vax pt developed RUQ pain which was constant and sharp, LFTs elevated. Lap chole in 12/2000 did not improve pain.  Pt. became depressed in 7/2000.  Diarrhea began 8/2000.  Acid reflux/gastritis dx in 8/2000.  Chostochondritis of the right anterior rib cage dx 11/2000.  Skin lesions returned 11/2000 dx as folliculitis with impetigo.  Medical discharge from the service in 12/2001. Pt. still c/o daily RUQ pain, fatigue, intermittent fevers, diffuse symmetrical joint pain with minimal swelling, and skin lesions. DX: Autoimmune hepatitis, Prurigo Nodularis, Transaminitis,  Neutrophilic Infiltrative Disease of unclear etiology, FUO.   05/04/2007 Clinical summary received beginning 1998 through 2004 with the following assessments:  Chronic right upper quadrant pain.  Chronic dermatitis.  Arthralgias.  Myalgias.  Fatigue.  Migraine H/As.  Insomnia.  GERD.  Memory loss.  Tachycardia resolved.  Hypertension.  FUO.  Liver disease-autoimmune.  Depression.
Age: 22.0
Sex: F
Vaccine: ANTH
Symptoms: Local reaction, Pain, Pain in extremity, Skin lesion
Clinical narrative: 1. Large local reaction within 2-3 days. Then whole arm and contiguous joint soreness, then other joints sore. 2. July 2000: RUQ pain started: constant, sharp, intermittently elevated LFTs with AST>700, ALT>600, alk phos 200 on at least 2 occasions (now normal lfts, but continuous pain controlled by chronic methadone). 3. Aug 2000: Chronic diarrhea started. 4. November 2000: skin lesions started. AF bx neutrophilic infiltrate. 5. Dec 2000 Lap choly. Now has chronic joint pain, RUQ pain, diarrhea, skin lesions.  03/13/2007 Lengthy MR received.  Initial visit with Infectious Disease MD 8/20/2002 with a 2 year hx of the following c/o:  Chronic RUQ pain, generalized arthralgias, fatigue, insomnia, chronic diarrhea, and skin lesions.  HPI:  Following Anthrax vax in 5/2000, pt initially noticed red bumps around the vaccination site which ultimately ulcerated.  These later progressed to diffuse involvement.  2-3 weeks following vax pt developed muscle soreness and difficulty moving her arm.  Joint pain in the elbow and shoulder followed which ultimately spread to all muscles and joints.  2 months following vax pt developed RUQ pain which was constant and sharp, LFTs elevated. Lap chole in 12/2000 did not improve pain.  Pt. became depressed in 7/2000.  Diarrhea began 8/2000.  Acid reflux/gastritis dx in 8/2000.  Chostochondritis of the right anterior rib cage dx 11/2000.  Skin lesions returned 11/2000 dx as folliculitis with impetigo.  Medical discharge from the service in 12/2001. Pt. still c/o daily RUQ pain, fatigue, intermittent fevers, diffuse symmetrical joint pain with minimal swelling, and skin lesions. DX: Autoimmune hepatitis, Prurigo Nodularis, Transaminitis,  Neutrophilic Infiltrative Disease of unclear etiology, FUO.   05/04/2007 Clinical summary received beginning 1998 through 2004 with the following assessments:  Chronic right upper quadrant pain.  Chronic dermatitis.  Arthralgias.  Myalgias.  Fatigue.  Migraine H/As.  Insomnia.  GERD.  Memory loss.  Tachycardia resolved.  Hypertension.  FUO.  Liver disease-autoimmune.  Depression.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Computerised tomogram normal, Dizziness, Feeling drunk, Gait disturbance, Stress
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 22 year old female student who on 27-NOV-2006 was vaccinated 0.5 ml IM in right deltoid with her first of Gardasil, lot #653938/0954F. The day after the vaccination, the patient felt lightheaded. She stated that she felt it was related to the stress of school. The second day after the vaccination she stated that she felt "drunk" and had trouble walking. The student health center sent her to the hospital by ambulance and she was admitted for two days. She had a head computed axial tomography (CT scan) performed which was within normal limits. Her diagnosis was vertigo (onset date reported as 29-NOV-2006). She was discharged with a prescription of meclizine. It was reported that she never filled the prescription because she was too busy with school and finals. There was no signs of reaction on right deltoid noted. No further information is available.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Vertigo
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 22 year old female student who on 27-NOV-2006 was vaccinated 0.5 ml IM in right deltoid with her first of Gardasil, lot #653938/0954F. The day after the vaccination, the patient felt lightheaded. She stated that she felt it was related to the stress of school. The second day after the vaccination she stated that she felt "drunk" and had trouble walking. The student health center sent her to the hospital by ambulance and she was admitted for two days. She had a head computed axial tomography (CT scan) performed which was within normal limits. Her diagnosis was vertigo (onset date reported as 29-NOV-2006). She was discharged with a prescription of meclizine. It was reported that she never filled the prescription because she was too busy with school and finals. There was no signs of reaction on right deltoid noted. No further information is available.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Computerised tomogram normal, Dizziness, Feeling drunk, Gait disturbance, Malaise
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 22 year old female student who on 27-NOV-2006 was vaccinated 0.5 ml IM in right deltoid with her first of Gardasil, lot #653938/0954F. The day after the vaccination, the patient felt lightheaded. She stated that she felt it was related to the stress of school. The second day after the vaccination she stated that she felt "drunk" and had trouble walking. The student health center sent her to the hospital by ambulance and she was admitted for two days. She had a head computed axial tomography (CT scan) performed which was within normal limits. Her diagnosis was vertigo (onset date reported as 29-NOV-2006). She was discharged with a prescription of meclizine. It was reported that she never filled the prescription because she was too busy with school and finals. There was no signs of reaction on right deltoid noted. No further information is available.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Autism, Measles
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Autism, Convulsion
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Amino acid level normal, Autism, Blood amino acid level normal, Chest X-ray normal, Convulsion
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Cough, Developmental delay, Electroencephalogram normal, Febrile convulsion, Loss of consciousness
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Mood altered, Nuclear magnetic resonance imaging brain normal, Pyrexia, Rash morbilliform, Somnolence
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Speech disorder developmental, Streptococcal identification test, Transferrin normal, Unresponsive to stimuli, Urine analysis normal
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 1.53
Sex: M
Vaccine: DTAP, HIBV, HIBV, DTAP, IPV, DTAP, DTAP, IPV, MMR
Symptoms: Viral infection, Vomiting
Clinical narrative: This case was reported by the mother of a consumer and described the occurrence of seizure in a 18-month-old male subject who was vaccinated with Infanrix for prophylaxis. A physician or other health care professional has not verified this report. Concurrent vaccination included inactivated poliomyelitis virus vaccine given on 14 February 2006. On 14 February 2006 the subject received a dose of Infanrix at 0.5ml. This was the 4th dose of Dtap vaccine received by the subject. Previous doses were another manufacturer brand.  On 20 February 2006, 6 days after vaccination with Infanrix, the subject experienced a seizure which resolved the same day. At an unspecified time following vaccination with Infanrix, the subject developed autistic characteristics noted during an evaluation by early developmental specialists. At the time of reporting, the subject was receiving 5 days of therapy for the autistic characteristics. The mother reported that her son was health prior to receiving his 18 month vaccinations. This case was assessed as medically serious by manufacturer. At the time of reporting the outcome of the events were was unspecified.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Blood culture, Bowel movement irregularity, Diarrhoea, Moaning, Vomiting
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Gastroenteritis, Hydronephrosis, Rotavirus test negative, Urinary tract infection
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Vomiting
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Escherichia infection, Gastroenteritis, Urinary tract infection, Vomiting
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Gastroenteritis, Hydronephrosis, Renal disorder, Rotavirus test negative
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Urinary tract infection, Vomiting
Clinical narrative: Developed vomiting and diarrhea (gastroenteritis) on 2/4/07-16 days after immunizations. Found to have urinary tract infection and mild hydronephrosis (underlying renal abnormality). Stool negative for rotavirus 2/9/02.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Blood culture, Bowel movement irregularity, Diarrhoea, Moaning, Vomiting
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Gastroenteritis, Hydronephrosis, Rotavirus test negative, Urinary tract infection
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Vomiting
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Escherichia infection, Gastroenteritis, Urinary tract infection, Vomiting
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Gastroenteritis, Hydronephrosis, Renal disorder, Rotavirus test negative
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Urinary tract infection, Vomiting
Clinical narrative: Information has been received from a physician concerning a 2 month old patient who on 19-JAN-2007 was vaccinated with Rotateq (no lot number provided). The physician reported that the patient experienced 5 rounds of vomiting, diarrhea and was admitted to the hospital on 04-FEB-2007 for "gastroenteritis". On 06-FEB-2007, the patient was discharged. On 09-FEB-2007, the patient was readmitted for a "urinary tract infection" and tested positive for "e-coli". On 12-FEB-2007, the patient was discharged again. The physician reported that the Vaccine information sheet was not given to the parents at the time of the vaccination, otherwise, the patient would not have been vaccinated. The patients outcome was reported as "improving". Additional information has been requested.
Age: 17.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Dystonia
Clinical narrative: Pt had a seizure post 15 hrs after injection 03/14/07-records received from facility 2/22/07-uncontrolled head shaking. Chronic abdominal pain. DX in ER Dystonic reaction.
Age: 17.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Convulsion
Clinical narrative: Pt had a seizure post 15 hrs after injection 03/14/07-records received from facility 2/22/07-uncontrolled head shaking. Chronic abdominal pain. DX in ER Dystonic reaction.
Age: 17.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Abdominal pain, Dyskinesia, Full blood count normal, Laboratory test normal
Clinical narrative: Pt had a seizure post 15 hrs after injection 03/14/07-records received from facility 2/22/07-uncontrolled head shaking. Chronic abdominal pain. DX in ER Dystonic reaction.